id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-P-4832-0005,FDA,FDA-2018-P-4832,"Final Response Letter from FDA CDER to Goodwin Procter LLP on behalf of Amneal
Pharmaceuticals LLC",Other,Denial of Petition,2024-10-02T04:00:00Z,2024,10,2024-10-02T04:00:00Z,,2024-10-02T19:55:27Z,,0,0,09000064867a7c47
FDA-2018-P-4832-0004,FDA,FDA-2018-P-4832,Interim Response Letter from FDA CDER to Goodwin Procter LLP,Other,Letter(s),2019-06-18T04:00:00Z,2019,6,2019-06-18T04:00:00Z,,2019-06-18T13:55:17Z,,0,0,0900006483d1e951
FDA-2018-P-4832-0001,FDA,FDA-2018-P-4832,Citizen Petition from Goodwin Procter LLP (on behalf of Amneal Pharmaceuticals LLC,Other,Citizen Petition,2018-12-21T05:00:00Z,2018,12,2018-12-21T05:00:00Z,2019-06-20T03:59:59Z,2024-10-02T19:44:40Z,,0,0,09000064839baa33
FDA-2018-P-4832-0002,FDA,FDA-2018-P-4832,Acknowledgment Letter from FDA DDM to Goodwin Procter LLP,Other,Acknowledgement Letter/Receipt,2018-12-21T05:00:00Z,2018,12,2018-12-21T05:00:00Z,,2018-12-21T21:08:36Z,,0,0,09000064839bad14